BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/9/2026 7:34:02 AM | Browse: 1 | Download: 7
 |
Received |
|
2025-10-10 06:55 |
|
Peer-Review Started |
|
2025-10-10 06:55 |
|
First Decision by Editorial Office Director |
|
2025-10-22 06:51 |
|
Return for Revision |
|
2025-10-22 06:51 |
|
Revised |
|
2025-11-05 06:28 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-12-18 02:40 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-12-18 08:56 |
|
Articles in Press |
|
2025-12-18 08:56 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-02-02 07:46 |
|
Publish the Manuscript Online |
|
2026-02-09 07:34 |
| ISSN |
1949-8462 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cardiac & Cardiovascular Systems |
| Manuscript Type |
Minireviews |
| Article Title |
Residual risk in atherosclerotic cardiovascular disease after statin therapy: Clinical mechanisms and management strategies
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Sze-Hua Tan, Jia-Lin Wu, Shu-Xiong Zhuo, Yi Zhang and Miao Wang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Shanghai Pudong New Area Health System Excellent Young Medical Talent Training Program |
No. PWRq2025-39 |
|
| Corresponding Author |
Miao Wang, Chief Physician, MD, PhD, Department of Internal Medicine of Traditional Chinese Medicine, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, No. 725 South Wanping Road, Xuhui District, Shanghai 200032, China. wangmiao_126@126.com |
| Key Words |
Atherosclerosis; Cardiovascular disease; Inflammation; Lipid metabolism; Lipoprotein(a); Residual risk; Statins; Triglycerides |
| Core Tip |
Residual cardiovascular risk remains in patients receiving statin therapy despite well-controlled low-density lipoprotein cholesterol. Key contributors include non-high-density lipoprotein cholesterol, apolipoprotein B, lipoprotein(a), triglycerides, and persistent inflammation marked by high-sensitivity C-reactive protein and interleukin-6. Comprehensive strategies combining novel lipid-lowering therapies, anti-inflammatory treatments, lifestyle modification, and gene-silencing approaches are essential to effectively reduce residual risk and improve long-term cardiovascular outcomes. |
| Publish Date |
2026-02-09 07:34 |
| Citation |
Tan SH, Wu JL, Zhuo SX, Zhang Y, Wang M. Residual risk in atherosclerotic cardiovascular disease after statin therapy: Clinical mechanisms and management strategies. World J Cardiol 2026; 18(2): 114960 |
| URL |
https://www.wjgnet.com/1949-8462/full/v18/i2/114960.htm |
| DOI |
https://dx.doi.org/10.4330/wjc.v18.i2.114960 |
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
